India's Dr. Reddy's Laboratories Gets Permission To Import Russia's Sputnik Vaccine
Mohammad Ali (@ChaudhryMAli88) Published April 13, 2021 | 01:10 PM
India's Drug Controller General (DCGI) has issued permission for Dr. Reddy's Laboratories, specialized in pharmacy, to import Russia's Sputnik V vaccine against COVID-19 to India for emergency use, the company said on Tuesday
MOSCOW (UrduPoint News / Sputnik - 13th April, 2021) India's Drug Controller General (DCGI) has issued permission for Dr. Reddy's Laboratories, specialized in pharmacy, to import Russia's Sputnik V vaccine against COVID-19 to India for emergency use, the company said on Tuesday.
On Monday, India became the 60th country to authorize use of Sputnik V. The Russian vaccine, developed by Moscow-based Gamaleya National Center, became the third vaccine registered in India along with the locally-produced variant of AstraZeneca vaccine branded Covieshield, and India's Covaxin.
"Dr. Reddy's Laboratories Ltd. ... today announced that it has received the permission from the Drug Controller General of India(DCGI) to import the Sputnik vaccine into India for restricted use in emergency situations as per the provisions of the New Drug and Clincial Trials rules, 2019 under the Drugs and Cosmetics Act," the press release, published on the website of Bombay Stock Exchange, said.
GV Prasad, the company's co-chairman and managing director, said that the enterprise was "very pleased to obtain the emergency use author[i]sation for Sputnik V in India" given that vaccines are the best instrument to contain the rising number of COVID-19 cases.
He added that this step "will enable us to contribute to our nation's effort of vaccinating a sign[i]ficant proportion of our population."
In September 2020, Dr. Reddy's Laboratories signed an agreement with the Russian Direct Investment Fund (RDIF), which promotes Sputnik V, to conduct clinical tests of the vaccine in India. In addition, RDIF has contracts with five Indian producers � Hetero Biopharma, Gland Pharma, Stelis Biopharma, Virchow Biotech, and Panacea Biotec � on the vaccine's manufacturing.
Related Topics
Recent Stories
Pakistan among nine poor countries that produces 90 percent cigarettes for world
Drug peddler arrested; 2310 grams hashish recovered
Bushra Bibi's medical tests conducted in best private hospital: NA told
Ambiguous terms in 'Nikah Nama' can't be used against bride: SC
Minister for Foreign Affairs Ishaq Dar renews Pakistan’s commitment to promoti ..
Provincial Transport Minister Bilal Akbar Khan visits general bus stand, inspect ..
Director General HDA for completing development work on Gulistan-e-Sarmast Hous ..
EU parliament's youngest lawmaker eyes re-election
Fake chilli factory unearthed
10 dead as floods wreak havoc in Kenyan capital
WASA launches comprehensive campaign to test quality of water
Food Authority team conducts operation in Jackson market harbor area
More Stories From Health
-
Vaccines save at least 154 million lives in 50 years: WHO
2 hours ago -
UHS to issue MBBS degrees within three months after final result
6 hours ago -
Rawalpindi woman gives birth to six babies
5 days ago -
DC calls for intensive anti-polio drive in ICT
6 days ago -
World Hemophilia Day observed to underscore importance of providing comprehensive care
7 days ago -
Six in a family with heart on the 'right side'
7 days ago
-
Diabetic disease increasing rapidly : Dr. Noor Elahi Memon
7 days ago -
World Hemophilia Day observed
7 days ago -
ATC dismisses bail petition of doctor involved in illegal kidneys transplant
15 days ago -
Dr. Shehzad warns against deviation from WHO guidelines on anti-smoking
15 days ago -
Health activists express concerns over attempts to derail tobacco control
17 days ago -
UHS declares MBBS first prof, MS urology exam results
26 days ago